mortality/aging
• embryos die prior to E7.5
|
Allele Symbol Allele Name Allele ID |
Ptentm1Ppp targeted mutation 1, Pier Paolo Pandolfi MGI:1857936 |
||||||||||||||||||||||||||||||||||||
Summary |
8 genotypes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• embryos die prior to E7.5
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• increased incidence of malignant tumors of various histological origins; age of incidence beginning at 6 months
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
Bannayan-Riley-Ruvalcaba syndrome | DOID:0050657 |
OMIM:158350 |
J:49532 | |
Cowden syndrome | DOID:6457 |
OMIM:PS158350 |
J:49532 |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• incomplete penetrance
• 40% of males died in utero
• 75% of females died in utero
|
• 25% exhibited local invasion within the prostate at 6 months of age
• tumor cells disrupted the basement membrane and were observed growing into the surrounding stroma
|
• prostates were enlarged, irregular, and contained papillary projections 2 to 3 months after birth
• prostate growths detectable by 3 months of age
• growths surpassed the size of seminal vesicles by 6 to 8 months of age
|
• hypercellular with enlargements of the anterior lobes
|
• hypercellular with enlargement of the dorsolateral lobes
|
• increased proliferation of epithelial cells
|
• 25% exhibited local invasion within the prostate at 6 months of age
• tumor cells disrupted the basement membrane and were observed growing into the surrounding stroma
|
• prostates were enlarged, irregular, and contained papillary projections 2 to 3 months after birth
• prostate growths detectable by 3 months of age
• growths surpassed the size of seminal vesicles by 6 to 8 months of age
|
• hypercellular with enlargements of the anterior lobes
|
• hypercellular with enlargement of the dorsolateral lobes
|
• increased proliferation of epithelial cells
|
• 25% exhibited local invasion within the prostate at 6 months of age
• tumor cells disrupted the basement membrane and were observed growing into the surrounding stroma
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• embryo morphology is stated to be indistinguishable from that of mutant mice wild-type for Pten
|
• cell death is reduced compared to mutant mice wild-type for Pten
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• following glucose injection, mice exhibit a greater increase in serum insulin levels compared with similarly treated wild-type mice
|
• mice exhibit impaired glucose tolerance that is not as severe as in Akt1tm1Nhy/Akt1tm1Nhy Akt2tm1Rsg/Akt2tm1Rsg mice
• however, mice exhibit normal glucose serum levels under normal conditions
|
• compared to in Akt2tm1Rsg homozygotes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• compared to in Akt2tm1Rsg homozygotes
|
• mice exhibit impaired glucose tolerance that is not as severe as in Akt2tm1Rsg homozygotes
|
|
|
♀ | phenotype observed in females |
♂ | phenotype observed in males |
N | normal phenotype |
• onset of lesions is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice; by 8 weeks of age, mutant prostates show pronounced cribriform and tufting of epithelial cells that are not seen until 12 weeks of age in single transgenic Tg(Pbsn-TAg)15Tvd mice
|
• onset of adenocarcinoma is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice, most likely due to a reduction in apoptosis
• some prostate abnormalities are different than in single transgenic Tg(Pbsn-TAg)15Tvd mice; pale cell carcinomas appear at around 17 weeks of age as do large focal adenocarcinomas with abundant cytoplasm and abnormal glandular growth patterns
• tumors show local microinvasion as well as invasion to distant sites in the urogenital system such as the seminal vesicle
|
• onset of mPIN is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice, most likely due to a reduction in apoptosis
• mPIN lesions increase in severity with age
|
• epithelial proliferation in the prostate remains similar to single transgenic Tg(Pbsn-TAg)15Tvd mice
• apoptosis in the prostate is reduced compared to single transgenic Tg(Pbsn-TAg)15Tvd mice
|
• onset of lesions is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice; by 8 weeks of age, mutant prostates show pronounced cribriform and tufting of epithelial cells that are not seen until 12 weeks of age in single transgenic Tg(Pbsn-TAg)15Tvd mice
|
• onset of adenocarcinoma is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice, most likely due to a reduction in apoptosis
• some prostate abnormalities are different than in single transgenic Tg(Pbsn-TAg)15Tvd mice; pale cell carcinomas appear at around 17 weeks of age as do large focal adenocarcinomas with abundant cytoplasm and abnormal glandular growth patterns
• tumors show local microinvasion as well as invasion to distant sites in the urogenital system such as the seminal vesicle
|
• onset of mPIN is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice, most likely due to a reduction in apoptosis
• mPIN lesions increase in severity with age
|
• epithelial proliferation in the prostate remains similar to single transgenic Tg(Pbsn-TAg)15Tvd mice
• apoptosis in the prostate is reduced compared to single transgenic Tg(Pbsn-TAg)15Tvd mice
|
• onset of lesions is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice; by 8 weeks of age, mutant prostates show pronounced cribriform and tufting of epithelial cells that are not seen until 12 weeks of age in single transgenic Tg(Pbsn-TAg)15Tvd mice
|
• onset of adenocarcinoma is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice, most likely due to a reduction in apoptosis
• some prostate abnormalities are different than in single transgenic Tg(Pbsn-TAg)15Tvd mice; pale cell carcinomas appear at around 17 weeks of age as do large focal adenocarcinomas with abundant cytoplasm and abnormal glandular growth patterns
• tumors show local microinvasion as well as invasion to distant sites in the urogenital system such as the seminal vesicle
|
• onset of mPIN is accelerated compared to single transgenic Tg(Pbsn-TAg)15Tvd mice, most likely due to a reduction in apoptosis
• mPIN lesions increase in severity with age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
prostate cancer | DOID:10283 |
OMIM:176807 OMIM:300147 OMIM:300704 OMIM:601518 OMIM:602759 OMIM:608656 OMIM:608658 OMIM:609299 OMIM:609558 OMIM:610321 OMIM:610997 OMIM:611100 OMIM:611868 OMIM:611928 OMIM:611955 OMIM:611958 OMIM:611959 |
J:103408 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|